EGFR inhibition can lead to the enrichment of the cancer stem cell subpopulation in non-small cell lung cancer, whether mutated or non-mutated in EGFR, through a NOTCH3-dependent process. This evidence concerns the gene EGFR and non-small cell lung carcinoma.